Hafiz Talha Javed
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Role not yet determined Is this you? Add your title
Also affiliated: University of Arkansas Medical Center (2026)
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Hafiz Talha Javed's research focuses on neurological disorders and treatments, particularly intracranial aneurysms and arteriovenous malformations. His work also investigates neuroprotective agents for acute ischemic stroke patients undergoing endovascular treatment. Javed has contributed to meta-analyses evaluating artificial intelligence tools for stroke detection and comparing Bruton’s tyrosine kinase (BTK) inhibitors for multiple sclerosis. Additionally, his research includes meta-analyses on IDH-targeted agents for lower-grade gliomas and the imaging features of leptomeningeal enhancement. He has authored six publications. Javed collaborates with researchers such as Krishna Nalleballe from the University of Arkansas at Little Rock and Sanjeeva Onteddu from the University of Arkansas for Medical Sciences.
Metrics
- Publications: 6
Selected Publications
-
Beyond the Typical Atypical Imaging Features of Leptomeningeal Enhancement: A Case Series (2026)
-
Catch More or Call Fewer? A Systematic Review and Meta-analysis comparing Viz.ai vs Rapid AI (P6-4.018) (2026)
-
Targeting B-cell Signaling in Multiple Sclerosis: A Meta-analysis of Bruton’s Tyrosine Kinase (BTK) Inhibitors (P4-18.001) (2026)
-
Evaluation of Neuroprotective Agents In Acute Ischemic Stroke Patients Undergoing Endovascular Treatment: A Systematic Review and Meta-analysis (P7-4.016) (2026)
-
Beyond Cytotoxic Therapy: A Meta-analysis of IDH-targeted Agents in Lower-grade Gliomas (P10-6.007) (2026)
Collaboration Network
Top Collaborators
- Beyond Cytotoxic Therapy: A Meta-analysis of IDH-targeted Agents in Lower-grade Gliomas (P10-6.007)
- Evaluation of Neuroprotective Agents In Acute Ischemic Stroke Patients Undergoing Endovascular Treatment: A Systematic Review and Meta-analysis (P7-4.016)
- Targeting B-cell Signaling in Multiple Sclerosis: A Meta-analysis of Bruton’s Tyrosine Kinase (BTK) Inhibitors (P4-18.001)
- Catch More or Call Fewer? A Systematic Review and Meta-analysis comparing Viz.ai vs Rapid AI (P6-4.018)
- Beyond Cytotoxic Therapy: A Meta-analysis of IDH-targeted Agents in Lower-grade Gliomas (P10-6.007)
- Evaluation of Neuroprotective Agents In Acute Ischemic Stroke Patients Undergoing Endovascular Treatment: A Systematic Review and Meta-analysis (P7-4.016)
- Targeting B-cell Signaling in Multiple Sclerosis: A Meta-analysis of Bruton’s Tyrosine Kinase (BTK) Inhibitors (P4-18.001)
- Catch More or Call Fewer? A Systematic Review and Meta-analysis comparing Viz.ai vs Rapid AI (P6-4.018)
- Beyond Cytotoxic Therapy: A Meta-analysis of IDH-targeted Agents in Lower-grade Gliomas (P10-6.007)
- Evaluation of Neuroprotective Agents In Acute Ischemic Stroke Patients Undergoing Endovascular Treatment: A Systematic Review and Meta-analysis (P7-4.016)
- Targeting B-cell Signaling in Multiple Sclerosis: A Meta-analysis of Bruton’s Tyrosine Kinase (BTK) Inhibitors (P4-18.001)
- Beyond Cytotoxic Therapy: A Meta-analysis of IDH-targeted Agents in Lower-grade Gliomas (P10-6.007)
- Targeting B-cell Signaling in Multiple Sclerosis: A Meta-analysis of Bruton’s Tyrosine Kinase (BTK) Inhibitors (P4-18.001)
- Catch More or Call Fewer? A Systematic Review and Meta-analysis comparing Viz.ai vs Rapid AI (P6-4.018)
- Beyond Cytotoxic Therapy: A Meta-analysis of IDH-targeted Agents in Lower-grade Gliomas (P10-6.007)
- Evaluation of Neuroprotective Agents In Acute Ischemic Stroke Patients Undergoing Endovascular Treatment: A Systematic Review and Meta-analysis (P7-4.016)
- Targeting B-cell Signaling in Multiple Sclerosis: A Meta-analysis of Bruton’s Tyrosine Kinase (BTK) Inhibitors (P4-18.001)
- Beyond Cytotoxic Therapy: A Meta-analysis of IDH-targeted Agents in Lower-grade Gliomas (P10-6.007)
- Targeting B-cell Signaling in Multiple Sclerosis: A Meta-analysis of Bruton’s Tyrosine Kinase (BTK) Inhibitors (P4-18.001)
- Beyond Cytotoxic Therapy: A Meta-analysis of IDH-targeted Agents in Lower-grade Gliomas (P10-6.007)
- Targeting B-cell Signaling in Multiple Sclerosis: A Meta-analysis of Bruton’s Tyrosine Kinase (BTK) Inhibitors (P4-18.001)
- Beyond Cytotoxic Therapy: A Meta-analysis of IDH-targeted Agents in Lower-grade Gliomas (P10-6.007)
- Targeting B-cell Signaling in Multiple Sclerosis: A Meta-analysis of Bruton’s Tyrosine Kinase (BTK) Inhibitors (P4-18.001)
- Beyond Cytotoxic Therapy: A Meta-analysis of IDH-targeted Agents in Lower-grade Gliomas (P10-6.007)
- Targeting B-cell Signaling in Multiple Sclerosis: A Meta-analysis of Bruton’s Tyrosine Kinase (BTK) Inhibitors (P4-18.001)
- Beyond Cytotoxic Therapy: A Meta-analysis of IDH-targeted Agents in Lower-grade Gliomas (P10-6.007)
- Targeting B-cell Signaling in Multiple Sclerosis: A Meta-analysis of Bruton’s Tyrosine Kinase (BTK) Inhibitors (P4-18.001)
- Evaluation of Neuroprotective Agents In Acute Ischemic Stroke Patients Undergoing Endovascular Treatment: A Systematic Review and Meta-analysis (P7-4.016)
- Catch More or Call Fewer? A Systematic Review and Meta-analysis comparing Viz.ai vs Rapid AI (P6-4.018)
- Evaluation of Neuroprotective Agents In Acute Ischemic Stroke Patients Undergoing Endovascular Treatment: A Systematic Review and Meta-analysis (P7-4.016)
- Catch More or Call Fewer? A Systematic Review and Meta-analysis comparing Viz.ai vs Rapid AI (P6-4.018)
- Evaluation of Neuroprotective Agents In Acute Ischemic Stroke Patients Undergoing Endovascular Treatment: A Systematic Review and Meta-analysis (P7-4.016)
- Evaluation of Neuroprotective Agents In Acute Ischemic Stroke Patients Undergoing Endovascular Treatment: A Systematic Review and Meta-analysis (P7-4.016)
- Evaluation of Neuroprotective Agents In Acute Ischemic Stroke Patients Undergoing Endovascular Treatment: A Systematic Review and Meta-analysis (P7-4.016)
Similar Researchers
Based on overlapping research topics